Climbing Safety

Business

Standex International Beats Q2 Estimates, Boosts Dividend Amid Stronger Growth Outlook

Standex International Corporation reported robust fiscal second-quarter results, with revenue climbing to $221.32 million and net income reaching $2.12 million. The company raised its quarterly dividend by 6.3% and issued an upbeat forecast for the third quarter, reinforcing confidence in its strategic shift toward high-value engineered products.

Jan 30, 2026

Business

San Francisco Rental Market Roars Back, Leading Nation in Price Surge

Fueled by a return-to-office push and AI sector optimism, San Francisco rents are climbing at their fastest rate in over a decade, starkly contrasting with cooling prices in Los Angeles.

Jan 30, 2026

Business

AI Data Surge Fuels Western Digital's Strong Q2, Drives High-Capacity Storage Demand

Western Digital's fiscal Q2 2026 results showcase robust growth, with revenue climbing 25% year-over-year to $3.0 billion. The company credits accelerating AI adoption for driving demand for its high-capacity nearline hard drives and advanced technologies like HAMR and UltraSMR.

Jan 30, 2026

Business

Baidu's Self-Driving Bet Gains Traction, Fueling Investor Debate on Future Value

As Baidu pivots from its search engine roots, its heavy investments in autonomous vehicle technology are beginning to yield operational results, reshaping analyst views and sparking fresh valuation discussions amidst fierce AI competition.

Feb 2, 2026

Business

Markets Reel as $10 Trillion Vaporizes from Gold, Silver, and Crypto in Liquidity Scramble

A synchronized plunge in traditional safe havens and digital assets has erased over $10 trillion in value, signaling a broad market reassessment of Federal Reserve policy and global liquidity conditions.

Feb 2, 2026

Business

From Hurricanes to Sentiment: Wintermute Predicts Crypto Prediction Markets Will Upend Insurance by 2026

A new report from crypto market maker Wintermute Ventures forecasts a seismic shift, arguing that blockchain-based prediction markets will begin displacing traditional insurance by making hyper-specific risks tradable. The firm outlines a future where decentralized infrastructure becomes the new clearing layer for a programmable global economy.

Feb 2, 2026

Business

Hess Midstream Charts Course for Cash Flow Surge as Major Infrastructure Build Nears Completion

Hess Midstream Partners LP (HESM) signals a pivotal shift towards robust free cash flow generation, forecasting a 40% drop in capital expenditures for 2026 as its core system build-out concludes. Despite near-term weather headwinds, strong minimum volume commitments underpin financial targets through 2028.

Feb 2, 2026

Business

Tyson Foods Posts Strong Q1 Sales, Navigates Beef Headwinds with Strategic Closures

Tyson Foods reported a 6.2% increase in Q1 2026 sales to $14.3 billion, driven by robust demand for protein. While the Chicken and Prepared Foods segments showed strength, the company is restructuring its Beef operations, closing one plant and scaling back another, to align with a constrained cattle supply outlook.

Feb 2, 2026

Business

Geopolitical Tremors Eclipse Fundamentals as Dominant Market Force in 2026

A volatile January has underscored a stark shift for investors: political shocks emanating from Washington now pose a greater threat to portfolios than traditional economic or earnings concerns, reshaping risk calculus across global markets.

Feb 2, 2026

Business

Building a Reliable Income Stream: How a $500 Stake in This Dividend ETF Can Pay Off Long-Term

The Schwab U.S. Dividend Equity ETF (SCHD) offers investors a balanced approach to generating income, targeting financially robust companies with a history of growing dividends. We examine its strategy, performance, and role in a portfolio.

Feb 2, 2026

Business

Aptiv Caps Strong 2025 with Record Q4 Revenue, Sets Stage for Versagen Spin-Off

Aptiv reported record fourth-quarter revenue of $5.2 billion, a 3% increase, as the automotive technology leader prepares to spin off its Electrical Distribution Systems business as the independent company Versagen on April 1, 2026.

Feb 2, 2026

From Coffee to Cookies: How New Tariffs Are Driving Up Prices on Imported Grocery Staples

Shoppers are bracing for another wave of price increases as new import taxes take effect, targeting a range of everyday items from spirits to seafood. Experts warn the hikes will squeeze household budgets and force tough choices at the supermarket.

Feb 2, 2026

Business

Scholar Rock's Soaring Stock: Is the Biotech's Momentum Justified or Overheated?

Shares of clinical-stage biotech Scholar Rock (NASDAQ: SRRK) have surged nearly 60% in three months, closing at $44.34. This rally, backed by promising clinical progress, has investors weighing its premium valuation against its long-term potential in treating serious diseases.

Feb 2, 2026

Business

ImmunityBio's Anktiva Shows Blockbuster Potential as Piper Sandler Eyes Label Expansion After QUILT Trial Data

Piper Sandler raises its price target on ImmunityBio, citing a near 700% surge in Anktiva sales and promising interim data from the QUILT trials that could support a major label expansion by 2027.

Feb 2, 2026

US

Repeat Offender in Arizona Border Shooting Incident Had History of Confrontations with Authorities

A suspected human smuggler with a prior conviction was shot by federal agents near the Arizona-Mexico border after allegedly firing at a CBP helicopter and agents during a foot pursuit, according to law enforcement officials.

Feb 2, 2026

US

Ohio Mother's Final Act of Love: Family of Three Lost in Devastating Cincinnati Blaze

A 68-year-old Cincinnati woman and her two adult children perished in a fast-moving house fire last month, with officials describing the conditions as 'not survivable.'

Feb 2, 2026

Business

Lexeo Therapeutics Faces Market Skepticism Despite Positive PKP2 Gene Therapy Data

H.C. Wainwright maintains a Buy rating on Lexeo Therapeutics but slashes its price target, citing persistent market doubts over the company's PKP2 cardiomyopathy program despite encouraging early clinical results.

Feb 2, 2026

Business

Aptiv Gains Analyst Favor as Strategic Shift Yields 'More Realistic' Growth Outlook

Aptiv PLC sees mixed but upwardly revised price targets from major analysts, with Piper Sandler upgrading the auto tech supplier to Overweight and naming it a top pick for 2026, citing its pragmatic strategy and attractive valuation.

Feb 2, 2026

Business

Mobileye Eyes 2026 as Pivotal Year Amid Analyst Backing and Strategic Shifts

Despite recent guidance revisions, Mobileye Global retains strong buy ratings from analysts who see significant upside potential, as the company positions 2026 for a strategic transition in the autonomous driving sector.

Feb 2, 2026

Business

Analysts See Long-Term Promise in Legend Biotech's Carvykti Despite Fourth-Quarter Sales Shortfall

While Legend Biotech's CAR-T therapy Carvykti missed Q4 sales estimates, prompting mixed analyst reactions, some firms emphasize its curative potential and view the stock's recent decline as a strategic entry point for investors.

Feb 2, 2026